Cargando…
Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies
SIMPLE SUMMARY: IL13Rα2 has been repeatedly reported as an excellent therapeutic target for multiple types of advanced cancers. However, previous IL13Rα2 targeting attempts have been mostly unsuccessful. Here, we describe a novel strategy based on the blocking of the IL-13 tumorigenic activity using...
Autores principales: | Jaén, Marta, Bartolomé, Rubén A., Aizpurua, Carmen, Martin-Regalado, Ángela, Imbaud, J. Ignacio, Casal, J. Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038733/ https://www.ncbi.nlm.nih.gov/pubmed/33917458 http://dx.doi.org/10.3390/cancers13071731 |
Ejemplares similares
-
An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer
por: Bartolomé, Rubén A., et al.
Publicado: (2018) -
IL13Rα2 signaling in colorectal cancer
por: Bartolomé, Rubén A., et al.
Publicado: (2015) -
Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells
por: Bartolomé, Rubén A., et al.
Publicado: (2020) -
CDH6‐activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers
por: Bartolomé, Rubén A., et al.
Publicado: (2021) -
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome
por: Robles, Javier, et al.
Publicado: (2022)